New ointment could ease blistering in rare skin disease
NCT ID NCT06073132
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an ointment called diacerein 1% on people with a rare genetic skin condition (EBS) that causes fragile skin and painful blisters. About 80 participants will apply the ointment daily to see if it clears blisters and reduces pain. The trial is double-blind, meaning neither patients nor doctors know who gets the real ointment versus a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED EPIDERMOLYSIS BULLOSA SIMPLEX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asian Hospital
City of Muntinlupa, Philippines
-
Children's Health Ireland
Dublin, Ireland
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Cincinnati Childrens Hospital
Cincinnati, Ohio, 45229, United States
-
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China
-
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano
Milan, Italy
-
Gangnam Severane Hospital
Seoul, South Korea
-
Great Ormond Street Hospital (GOSH) for Children NHS Foundation Trust - Somers Clinical Research Facility (CRF)
London, United Kingdom
-
Health Cube Medical Clinics
Mandaluyong, Philippines
-
Hospital Tunku Azizah (Hospital Wanita Dan Kanak-kanak Kuala Lumpur)
Kuala Lumpur, Malaysia
-
Hospital Universitario La Paz
Madrid, Spain
-
Hospital of Skin and Venereal Diseases of Thessaloniki
Thessaloniki, Greece
-
Iloilo Doctors Hospital
Iloilo City, Philippines
-
Istituto Dermopatico dell'Immacolata (IDI) - Istituto di
Rome, Italy
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Mission dermatology Center
Rancho Santa Margarita, California, 92688, United States
-
National Cheng Kung University Hospital
Tainan, Taiwan
-
Northwestern University - Lurie Childrens's Hospital
Chicago, Illinois, 60611, United States
-
OT.CO Clinic Osipowicz & Turkowski
Warsaw, Poland
-
Postgraduate Institute of Medical Education and Research (PGIMER)
Chandigarh, India
-
Premier Specialists
Kogarah, Australia
-
Sheikh Khalifa Medical City (SKMC)
Abu Dhabi, United Arab Emirates
-
Stanford University
Stanford, California, 94304, United States
-
Sydney Children's Hospital
Randwick, Australia
-
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
-
Texas Dermatology and Laser Specialists
San Antonio, Texas, 78218, United States
-
UOS "Centro delle Dermatosi Croniche Complesse e Genodermatosi" UOC Dermatologia
Rome, Italy
-
UZ Leuven
Leuven, Belgium
-
Universitaetsklinik fuer Dermatologie und Allergologie
Salzburg, Austria
-
Università degli Studi di Modena e Reggio Emilia (UNIMORE)
Modena, Italy